Browsing: Respiratory

In conjunction with Institut Kanser Negara’s (IKN) 10th anniversary, AstraZeneca announced its collaboration to accelerate digitalisation in healthcare by introducing Artificial Intelligence (AI) x-ray technology into early lung screening at government clinics and hospitals under the Projek Saringan Awal Paru-Paru (SAPU) programme. As a centre of excellence for cancer care in the country, IKN will be the first government institution in the country to implement this AI technology.

Log In or Register as a healthcare professional to read the full article.

The US Food and Drug Administration (FDA) has greenlit new COVID-19 boosters for both Moderna and Pfizer, marking a proactive step in the fight against rapidly spreading infections in the country. Concurrently, Moderna and Pfizer have announced that their updated COVID-19 vaccines show a robust response against the BA.2.86 subvariant, a mutated version of the coronavirus.

Recent data from the Jakarta Health Agency revealed an uptick in Acute Respiratory Infections (ISPA) post-pandemic cases. The agency reported approximately 146,000 ISPA cases monthly this year. Interestingly, while this is higher than the pandemic period, it’s still consistent with the numbers from 2018 and 2019.

Seasonal flu, also known as influenza, is a recurrent global health concern. It’s a viral infection, primarily attacking the respiratory system. Symptoms can range from mild to severe, with complications like pneumonia being potentially fatal.